Literature DB >> 28374152

Uric acid activates NRLP3 inflammasome in an in-vivo model of epithelial to mesenchymal transition in the kidney.

César Andrés Romero1, Aline Remor2, Alexandra Latini2, Ana Lucía De Paul1, Alicia Inés Torres1, Jorge Humberto Mukdsi3.   

Abstract

Uric acid (UA) has been associated with renal fibrosis and progression of chronic kidney disease. However, the underlying mechanisms of this process have still not been identified. Here, we studied the role of the innate imunity receptor NLRP3/ASC in UA induced epithelial-mesenchymal transition (EMT) in kidney. Wistar rats were fed with oxonic acid 2% and UA 2% (OXA + U), OXA + U plus allopurinol (ALL) or regular chow (C) for 7 weeks. We analyzed the presence of EMT markers, the expression of NLRP3, ASC, Caspase-1 and Smad 2/3 molecules and the mitochondrial morphological and functional characteristics. High UA induced renal fibrosis, mild chronic inflammation, as well as morphological and biochemical evidence of EMT. High UA also increased the expression of NLRP3/ASC with activation of both inflammasome related caspase-1 and inflammasome unrelated Smad 2/3 pathways. Ultrastructural co-localization of NLRP3 and Smad 2/3 indicated physical interaction between the two molecules. No morphological or functional changes were found between mitochondria exposed to high UA. In conclusion, kidney epithelial NLRP3/ASC expression was increased in high UA state in rats and both inflammasome related caspase-1 and non-inflammasome related P-Smad 2/3 pathways were associated with the observed EMT, inflammation and fibrosis induced by UA in the kidney.

Entities:  

Keywords:  Epithelial-mesenchymal transition; Kidney; Mitochondria; NLRP3/ASC; Smad 2/3; Uric acid

Mesh:

Substances:

Year:  2017        PMID: 28374152     DOI: 10.1007/s10735-017-9720-9

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  38 in total

1.  Involvement of MEK/ERK1/2 and PI3K/Akt pathways in the refractory behavior of GH3B6 pituitary tumor cells to the inhibitory effect of TGFβ1.

Authors:  Juan Pablo Petiti; Liliana del Valle Sosa; María Eugenia Sabatino; Alicia Maldré Vaca; Silvina Gutiérrez; Ana Lucía De Paul; Alicia Inés Torres
Journal:  Endocrinology       Date:  2014-11-13       Impact factor: 4.736

Review 2.  Mechanism of NLRP3 inflammasome activation.

Authors:  Fayyaz S Sutterwala; Stefanie Haasken; Suzanne L Cassel
Journal:  Ann N Y Acad Sci       Date:  2014-05-19       Impact factor: 5.691

3.  A role for mitochondria in NLRP3 inflammasome activation.

Authors:  Rongbin Zhou; Amir S Yazdi; Philippe Menu; Jürg Tschopp
Journal:  Nature       Date:  2010-12-01       Impact factor: 49.962

Review 4.  Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy?

Authors:  Wilhelm Kriz; Brigitte Kaissling; Michel Le Hir
Journal:  J Clin Invest       Date:  2011-02       Impact factor: 14.808

5.  Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction.

Authors:  K A Hruska; G Guo; M Wozniak; D Martin; S Miller; H Liapis; K Loveday; S Klahr; T K Sampath; J Morrissey
Journal:  Am J Physiol Renal Physiol       Date:  2000-07

6.  Inflammasome activation by mitochondrial oxidative stress in macrophages leads to the development of angiotensin II-induced aortic aneurysm.

Authors:  Fumitake Usui; Koumei Shirasuna; Hiroaki Kimura; Kazuki Tatsumi; Akira Kawashima; Tadayoshi Karasawa; Koichi Yoshimura; Hiroki Aoki; Hiroko Tsutsui; Tetsuo Noda; Junji Sagara; Shun'ichiro Taniguchi; Masafumi Takahashi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-11-06       Impact factor: 8.311

7.  Hyperuricemia and Progression of CKD in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort Study.

Authors:  Kyle E Rodenbach; Michael F Schneider; Susan L Furth; Marva M Moxey-Mims; Mark M Mitsnefes; Donald J Weaver; Bradley A Warady; George J Schwartz
Journal:  Am J Kidney Dis       Date:  2015-07-21       Impact factor: 8.860

8.  Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport.

Authors:  A Cassina; R Radi
Journal:  Arch Biochem Biophys       Date:  1996-04-15       Impact factor: 4.013

9.  Inflammasome-independent NLRP3 augments TGF-β signaling in kidney epithelium.

Authors:  Wenjie Wang; Xiangyu Wang; Justin Chun; Akosua Vilaysane; Sharon Clark; Gabrielle French; Nathan A Bracey; Kiril Trpkov; Shirin Bonni; Henry J Duff; Paul L Beck; Daniel A Muruve
Journal:  J Immunol       Date:  2012-12-21       Impact factor: 5.422

Review 10.  A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010.

Authors:  Katherine T Mills; Yu Xu; Weidong Zhang; Joshua D Bundy; Chung-Shiuan Chen; Tanika N Kelly; Jing Chen; Jiang He
Journal:  Kidney Int       Date:  2015-07-29       Impact factor: 10.612

View more
  11 in total

1.  Renal release of N-acetyl-seryl-aspartyl-lysyl-proline is part of an antifibrotic peptidergic system in the kidney.

Authors:  Cesar A Romero; Nitin Kumar; Pablo Nakagawa; Morel E Worou; Tang-Dong Liao; Edward L Peterson; Oscar A Carretero
Journal:  Am J Physiol Renal Physiol       Date:  2018-11-07

2.  Mst1 facilitates hyperglycemia-induced retinal pigmented epithelial cell apoptosis by evoking mitochondrial stress and activating the Smad2 signaling pathway.

Authors:  Bing Wei; Min Wang; Wei Hao; Xiangdong He
Journal:  Cell Stress Chaperones       Date:  2019-01-10       Impact factor: 3.667

Review 3.  Role of Inflammasomes in Keloids and Hypertrophic Scars-Lessons Learned from Chronic Diabetic Wounds and Skin Fibrosis.

Authors:  Chenyu Huang; Rei Ogawa
Journal:  Int J Mol Sci       Date:  2022-06-19       Impact factor: 6.208

Review 4.  Inflammasome as an Effective Platform for Fibrosis Therapy.

Authors:  Ting-Ting Chen; Feng Xiao; Nan Li; Shan Shan; Meng Qi; Zi-Ying Wang; Sheng-Nan Zhang; Wei Wei; Wu-Yi Sun
Journal:  J Inflamm Res       Date:  2021-04-20

5.  Induction of Autophagy by Pterostilbene Contributes to the Prevention of Renal Fibrosis via Attenuating NLRP3 Inflammasome Activation and Epithelial-Mesenchymal Transition.

Authors:  Ying-Jan Wang; Yu-Ying Chen; Ching-Mao Hsiao; Min-Hsiung Pan; Bour-Jr Wang; Yu-Chi Chen; Chi-Tang Ho; Kuo-Ching Huang; Rong-Jane Chen
Journal:  Front Cell Dev Biol       Date:  2020-06-03

Review 6.  Parasite Recognition and Signaling Mechanisms in Innate Immune Responses to Malaria.

Authors:  D Channe Gowda; Xianzhu Wu
Journal:  Front Immunol       Date:  2018-12-19       Impact factor: 7.561

7.  Serum testosterone acts as a prognostic indicator in polycystic ovary syndrome-associated kidney injury.

Authors:  Yali Song; Wenting Ye; Huiyun Ye; Tingting Xie; Weiwei Shen; Lili Zhou
Journal:  Physiol Rep       Date:  2019-08

Review 8.  Effect and Regulation of the NLRP3 Inflammasome During Renal Fibrosis.

Authors:  Hong Zhang; Zhengchao Wang
Journal:  Front Cell Dev Biol       Date:  2020-01-24

Review 9.  Reversal of Epithelial-Mesenchymal Transition by Natural Anti-Inflammatory and Pro-Resolving Lipids.

Authors:  Chang Hoon Lee
Journal:  Cancers (Basel)       Date:  2019-11-21       Impact factor: 6.639

10.  Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension.

Authors:  Shalini M Krishnan; Yeong H Ling; Brooke M Huuskes; Dorota M Ferens; Narbada Saini; Christopher T Chan; Henry Diep; Michelle M Kett; Chrishan S Samuel; Barbara K Kemp-Harper; Avril A B Robertson; Matthew A Cooper; Karlheinz Peter; Eicke Latz; Ashley S Mansell; Christopher G Sobey; Grant R Drummond; Antony Vinh
Journal:  Cardiovasc Res       Date:  2019-03-15       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.